mPath Health is a technology company.
mPath Health has raised $1.7M across 2 funding rounds.
mPath Health has raised $1.7M in total across 2 funding rounds.
mPath Health has raised $1.7M in total across 2 funding rounds.
mPath Health's investors include Alpha Venture Partners, VentureSouth.
# mPath Health: High-Level Overview
mPath Health is a digital health company dedicated to transforming preventive cancer screening through automation and behavioral science.[3] The company builds a cloud-based platform called mPATH® that identifies individuals who need preventive care services, provides personalized education, and connects them to needed care.[1] mPath Health serves healthcare systems and their patients, solving the critical problem of missed preventive screenings by automating outreach and enabling patients to access screening services on their own devices.[2] The company has demonstrated early traction, with implementations identifying over 3,500 patients overdue for colorectal cancer screening at Atrium Health Wake Forest Baptist, and recently secured $3 million in funding to expand its cancer screening and preventive health initiatives.[4]
mPath Health emerged from innovation at Atrium Health Wake Forest Baptist, where the mPATH platform was initially developed and refined.[2] The technology was subsequently licensed to Digital Health Navigation Solutions, Inc. (DHN Solutions), which now develops and commercializes additional mPATH modules for preventive and chronic care needs.[2] The company is headquartered in Winston Salem, North Carolina, positioning it within a growing digital health ecosystem focused on cancer prevention and health equity.[4][5]
mPath Health operates at the intersection of several powerful healthcare trends: the shift toward preventive care, the digitization of patient engagement, and the growing emphasis on health equity. As healthcare systems face mounting pressure to improve quality metrics and reduce costs, automation tools that identify and engage at-risk populations become increasingly valuable. The company's focus on cancer screening—where significant disparities exist and screening rates remain suboptimal—addresses a high-impact clinical need. By embedding behavioral science into digital workflows, mPath Health exemplifies how technology can bridge the gap between clinical recommendations and patient action, a challenge that has historically limited the effectiveness of preventive care initiatives.
mPath Health is positioned to capitalize on healthcare systems' urgent need to improve preventive care metrics and reduce screening disparities. The $3 million funding round signals investor confidence in the market opportunity and the company's execution. As the company expands its module library beyond cancer screening to other preventive and chronic care services, it has the potential to become a foundational platform for patient engagement across multiple clinical domains. The key to sustained growth will be demonstrating measurable improvements in both screening rates and health equity outcomes, while maintaining seamless integration with diverse healthcare IT environments. In a healthcare landscape increasingly focused on prevention and value-based care, mPath Health's ability to automate and personalize patient outreach addresses a fundamental operational challenge facing health systems nationwide.
mPath Health has raised $1.7M across 2 funding rounds. Most recently, it raised $1.0M Seed in October 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2024 | $1.0M Seed | Alpha Venture Partners | |
| Mar 1, 2024 | $710K Seed | Alpha Venture Partners, VentureSouth |